Difference between revisions of "CT Volumetry Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
 
(209 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Project Snapshot==
+
{{TOCright}}
*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
+
:Co-chairs: Ritu Gill, MD, MPH, Rudresh Jarecha, MBBS, DNB, DMRE, and Ehsan Samei, PhD 
 
 
*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
 
*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
 
'''[[:Category:Datasets| See the Datasets page]]''' of the [[Catalog|QIBA Resource Catalog]]
 
  
==Meetings / Call Summaries==
+
* [http://tinyurl.com/QIBA-CT-Vol-Roster Roster]
*[[Call Summaries]]
+
* [https://docs.google.com/spreadsheets/d/1qbBHaJNTAqHnAcmCTHsNfDph7hMyJ3NoUjYSdilVw8w/edit#gid=267283460 Attendance & Voting Privileges]
  
==Profile Development==
 
  
===Advanced Disease/Tumor Volume Change Profile===
+
'''Recent Call Summaries:'''
Status - Now Resolving Public Comment  
+
*[[Media:03 21 2023 QIBA CT Volumetry BC Call-FINAL.pdf|03.21.2023 QIBA CT Volumetry BC Call Summary]]
 +
   
  
*[[Media:QIBA_CVol_TumorVolumeChangeProfile - Claim language - Merged20141027.doc|QIBA Profile: Tumor Volume Change Claim Language - Work in Progress]] ''29October2014''
 
  
*[[Media:QIBA CVol TumorVolumeChange Clinical Context and Claims 2014 09 17.doc|QIBA Profile: Tumor Volume Change  Clinical Context and Claims -Work in Progress]] ''17September2014''
+
'''''[[CT Volumetry BC Call Summaries Archive]]'''''
  
*[[Media:QIBA CVol TumorVolumeChangeProfile 2014 08 15.doc|QIBA Profile: Tumor Volume Change Profile v2.3b]] ''15August2014''
+
==Profile Development==
 +
'''Streamlined Profile (also on Profile page)'''
 +
* [[Media:QIBACTVol_TumorVolumeChange(2022)-20220721.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-21 Streamlined Profile]]
 +
:* 32 pages including Conformance Checklists
  
*[[Media:QIBA CT Vol TumorVolumeChangeProfile (with additional compliance work) v2.3b 11 April 2014.doc|QIBA Profile: Tumor Change Profile v2.3b]] ''20May2014''
 
  
 +
'''Status - Balloting Streamlined Profile'''
 +
*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20220303.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2022.03.03
 +
*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20211209.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2021.12.09
  
[[Archived Versions]] of QIBA draft CT Volumetry Profile-related documents.
+
The Technically Confirmed Profile is on the [[Profiles]] page.
  
===Lung Nodule Assessment in CT Screening===
+
'''Stage 4 Planning'''
Status - Initial Profile Development
+
:* [https://docs.google.com/document/d/1Wcmkzp8N_2lLL-FCykNPwgsn1BJOs7Z9A1ZyTIkuGCo/edit?usp=sharing Draft Stage 4 Plan - Google Doc]
  
*[[Media:QIBA CT Vol Tumor Volume Change, 02.05.2014-2.doc|QIBA Profile: CT Volumetry: Lung Nodule Volume Assessment and Monitoring in Lung Cancer Screening, 02.05.2014'']] '5February2014' 
+
'''Past and Future'''
 
+
:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
*[[Archive for Lung Nodule Assessment in CT Screening Draft Profiles]]
+
:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
 
 
*[[Lung Nodule Assessment in CT Screening Call Summary Archive]]
 
  
 
==Groundwork Projects==
 
==Groundwork Projects==
Line 44: Line 42:
  
 
*[[Media:NIBIB-2 Proposal for CT Volumetry 16APR2012.pdf|NIBIB-2 Proposal for CT Volumetry]]''16-APR-2012''
 
*[[Media:NIBIB-2 Proposal for CT Volumetry 16APR2012.pdf|NIBIB-2 Proposal for CT Volumetry]]''16-APR-2012''
 
==Working Documents==
 
  
 
==Reference Materials==
 
==Reference Materials==
  
==2012==
+
'''2012'''
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 +
*[[Media:Why QIBA CT specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
  
==2011==
+
'''2011'''
 
*Dr Petrick's 2011 SPIE Presentation Materials
 
*Dr Petrick's 2011 SPIE Presentation Materials
 
*[[Media:Spie2011 NP QIBA1A-Talk-v05-final-1.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk]]
 
*[[Media:Spie2011 NP QIBA1A-Talk-v05-final-1.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk]]
 
*[[Media:Spie2011 NP QIBA1A-Paper-v08-final-2.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Paper]]
 
*[[Media:Spie2011 NP QIBA1A-Paper-v08-final-2.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Paper]]
 +
*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
  
==2010==
+
'''2010'''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 +
*[[Media:Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
  
 
==Reference Articles==
 
==Reference Articles==
Line 69: Line 68:
 
*[[Archive - Initial Target Selection and Roadmap]]
 
*[[Archive - Initial Target Selection and Roadmap]]
  
==Round 1 of QIBA Funded Projects==
+
==QIBA Funded Projects==
  
 +
'''Round 1'''
 
*[[Duke University]]
 
*[[Duke University]]
 
*[[Columbia University Medical Center]]
 
*[[Columbia University Medical Center]]
Line 77: Line 77:
 
*[[CoreLab Partners, Inc.]]
 
*[[CoreLab Partners, Inc.]]
  
==Round 2 of QIBA Funded Projects==
+
'''Round 2'''
 
 
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
 +
 +
'''Round 3'''
 +
*[[Media:Second 3A Statistical and Image Processing Analysis.pdf| Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)]]
 +
 +
'''Round 4'''
 +
*[[Media:Methodology and Reference Image Set for Volumetric Characterization and Compliance.pdf| Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)]]
 +
 +
*[[Media:Phantoms for CT Volumetry of Hepatic and Nodal Metastasis.pdf| Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)]]
 +
 +
'''Round 5'''
 +
*[[Media:Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization.pdf| Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)]]
 +
 +
'''Round 6'''
 +
*[[Media:Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology.pdf| Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)]]

Latest revision as of 19:14, 17 January 2024

Co-chairs: Ritu Gill, MD, MPH, Rudresh Jarecha, MBBS, DNB, DMRE, and Ehsan Samei, PhD


Recent Call Summaries:


CT Volumetry BC Call Summaries Archive

Profile Development

Streamlined Profile (also on Profile page)

  • 32 pages including Conformance Checklists


Status - Balloting Streamlined Profile

The Technically Confirmed Profile is on the Profiles page.

Stage 4 Planning

Past and Future

Groundwork Projects

These projects investigate (and resolve) scientific questions underlying QIBA Profile work.

  • VolCT - Group 1A - Analyze Bias/Variance where Ground Truth is Known Deterministically
  • VolCT - Group 1B - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
  • VolCT - Group 1C - Model Sources of Variability from a Systems Engineering Analysis
  • VolCT - Group 3A - Characterize variability due to algorithms (using phantoms / clinical data)
  • VolCT - Group 3B - Characterize clinical utility/efficacy with respect to clinical endpoints
  • VolCT - Colorado Group - Quantifying variability in measurement of pulmonary nodule

Reference Materials

2012

2011

2010

Reference Articles

  • Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. Academic Radiology
  • Radiology 2007 - Coronary Calcium Scoring - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses similar issues (e.g. achieving "standard" noise levels). It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
  • Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. Academic Radiology
  • Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. Academic Radiology

QIBA Funded Projects

Round 1

Round 2

Round 3

Round 4

Round 5

Round 6